Slow Weight Loss on GLP-1: Does Slow Mean It Is Not Working?

A slow pace can feel disappointing when your feed is full of dramatic weekly changes. But social media isn't a representative dataset: people share selectively, measure differently, and the most striking stories travel furthest (more on that in why before-and-after stories don't tell the whole story). Slower progress doesn't automatically mean a medicine isn't working, and faster progress doesn't guarantee a better long-term result for everyone.

What studies actually report

Trials measure average changes in groups over set periods, usually with structured follow-up and specific eligibility rules. In the STEP 1 trial, adults with overweight or obesity (without diabetes) on semaglutide 2.4 mg lost about 15% of their weight on average—but that was measured at week 68. Within any trial, some people lose much more than the average and some much less.

Real life adds more variation. In one US health-system study, people who stayed on a GLP-1 for two years lost about 9% of their weight on average, with large differences between individuals, and many people stopped along the way because of side effects, insurance changes or losing touch with their prescriber. A 2026 systematic review of low response found that factors such as higher starting BMI, higher HbA1c and insulin resistance, male sex, older age and shorter time on treatment were linked with smaller average losses. These are group-level patterns, not an explanation for any one person.

Why time matters—but isn't the whole story

Many medicines start at a low dose and step up gradually, so your first months may not reflect a full maintenance dose. Still, "just give it more time" shouldn't replace a prescriber review if your agreed goals—weight, glucose, symptoms or something else—aren't improving. Sticking with treatment means following the prescribed plan, not escalating it yourself or using extra medicine when the scale disappoints.

How to measure progress more fairly

If you and your clinician agree weighing is useful, weigh under consistent conditions and watch the trend over weeks rather than day-to-day changes. A weight-loss percentage calculator can put your progress in the same terms studies use. Other health markers matter too, so note side effects, appetite, activity and practical barriers. The purpose of tracking is to support a conversation—not to prove you "deserve" treatment.

Questions to ask

• What response should I expect for my specific medicine and reason for treatment?
• Over what period will we judge whether it's working?
• What could explain my current pattern?

Discuss alternatives only with your prescribing clinician, who can weigh risks, benefits and local options. And if a medicine is making it hard to eat, drink or get through your day, say so—even if you're losing some weight.

Slow progress isn't a moral verdict. It's one piece of information in a longer treatment story.